Le JDB : Jean-Philippe Milon, directeur général de Quantum Genomics

from Le Journal des Biotechs · host BOURSORAMA

La biotech a annoncé lundi un accord de licence pour son actif le plus avancé -Firibastat- avec le groupe chinois Qilu Pharmaceuticals. L'occasion pour Jean-Philippe Milon, directeur général de Quantum Genomics, de revenir sur les essais en cours dans l'hypertension artérielle résistante et dans l'insuffisance cardiaque.Hébergé par Audiomeans. Visitez audiomeans.fr/politique-de-confidentialite pour plus d'informations.

Episode metadata supplied by the publisher feed · Published Oct 30, 2020

Embed this episode

Attribution link and audio player

NOW PLAYING

Le JDB : Jean-Philippe Milon, directeur général de Quantum Genomics

0:00 12:28

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Le Journal des Biotechs?

This episode is 12 minutes long.

When was this Le Journal des Biotechs episode published?

This episode was published on October 30, 2020.

Can I download this Le Journal des Biotechs episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!